News Comirnaty Receives Full FDA Approval for Expanded Age Group July 8, 2022 Read More » Mylan Recalls One Lot of Insulin Glargine July 6, 2022 Read More » Pharmacists Now Able to Prescribe Paxlovid July 6, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in July July 1, 2022 Read More » Copiktra May Increase Risk for Cancer Patients June 30, 2022 Read More » Zelnorm Withdrawn from Market June 30, 2022 Read More » FDA Updates Evusheld Dosing Recommendations June 29, 2022 Read More » Breyanzi Wins Broader Use in Large B-Cell Lymphoma Treatment June 24, 2022 Read More » Tafinlar and Mekinist Approved to Treat Solid Tumors June 23, 2022 Read More » Page1 … Page27 Page28 Page29 Page30 Page31 … Page41 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in July July 1, 2022 Read More »